HCAT vs TDOC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

HCAT

56.9
AI Score
VS
HCAT Wins

TDOC

44.5
AI Score

Investment Advisor Scores

HCAT

57score
Recommendation
BUY

TDOC

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HCAT TDOC Winner
Forward P/E 10 303.0303 HCAT
PEG Ratio 0 -1.01 Tie
Revenue Growth -12.7% -4.0% TDOC
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 56.9/100 44.5/100 HCAT
Profit Margin -90.6% -7.1% TDOC
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD HCAT

Relative Price Performance (Last 90 Days)

HCAT 1M: -7.9% · 3M: -13.4% TDOC 1M: -0.8% · 3M: -27.3%

Current Technical Phase

HCAT

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -7.8%) with fading momentum, RSI 48

RSI (14): 48.2 · Price: $1.74

TDOC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 56.5 · Price: $6.30

Fundamentals Snapshot

Metric HCAT TDOC
Market Cap — —
Forward P/E 232.0 -8.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.1% 0.0%
Gross Margin 0.5% 0.7%
Operating Margin -0.1% -0.1%
EPS -3.69 -0.99
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HCAT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.